Drug
Atacand
Atacand is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
3
60%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 43 (60.0%)
Trials by Status
not_yet_recruiting120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_4
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
NCT07547878
completedphase_4
The Precision Hypertension Care Study
NCT02774460
completedphase_1
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
NCT02254447
completedphase_3
TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
NCT00227318
completedphase_4
Angiotensin-II Blockade in Mitral Regurgitation
NCT00587470
Clinical Trials (5)
Showing 5 of 5 trials
NCT07547878Phase 4
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
NCT02774460Phase 4
The Precision Hypertension Care Study
NCT02254447Phase 1
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
NCT00227318Phase 3
TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
NCT00587470Phase 4
Angiotensin-II Blockade in Mitral Regurgitation
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5